Federal bill targets bleeding disorder gaps for women and underserved groups

What does this do?

HR 8794 requires the Department of Health and Human Services to review existing research, provider training, and treatment access for bleeding disorders such as hemophilia and von Willebrand disease. The agency must publish a public report with findings and recommendations within two years, accepting public comments during the process. The bill also establishes a national public education campaign reaching patients and healthcare providers, with materials in multiple languages and cultural contexts distributed to schools, health departments, and medical facilities.

Who does it affect?

Women and girls with bleeding disorders, particularly those who are undiagnosed or live in areas with limited healthcare access, are the primary focus. Pediatricians, OB-GYNs, school nurses, and other medical providers are also targeted by the campaign and review.

Why does it matter?

The bill identifies gaps in diagnosis and interagency coordination, noting that many patients wait over 16 years for a correct diagnosis. Federal agencies would be directed to assess where those gaps exist and how to better collaborate on the issue.

What does it cost, and who pays?

• Up to $50M authorized
• Five-year funding window
• Awareness campaign only

Where does it stand?